Stevanato Group

Activities: Pharmaceutical

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
  2. Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer The company has received regulatory approval from the MHRA and Regional Ethics Committee to initiate its OVACT Phase I/Ib clinical trial of CryptiVax-1001, an off-the-shelf...
  3. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Britain's biotech potential (part I): world-class science, second-class support? The UK produces top-tier life sciences research, offers favourable conditions for early-stage investment and hosts a growing network of internationally competitive clusters. So...
  5. UK REACH reform falls short as industry warns of £500m+ compliance bill The UK chemicals industry has condemned the Government's long-awaited response to the UK REACH Alternative Transitional Registration model consultation, arguing it does little...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Distribution

How advanced injectables are redefining biopharma supply chain strategy

Demanding greater flexibility, regulatory rigour and end-to-end collaboration to ensure reliable global delivery, the rise of complex injectable therapies is pushing biopharmaceutical supply chains to evolve
Finance

Stevanato Group reports revenue of €280.0m for the second quarter of 2025

Company delivers 8% revenue growth, expanded margins and maintains fiscal year 2025 guidance
Sustainability

Manufacturing Chemist Stand Side with Stevanato Group

We discover what exhibitors at Pharmapack 2025 are showcasing LIVE!
Packaging

Nipro launches D2F Glass Vials powered by Stevanato Group's EZ-fill Technology

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F (Direct-to-Fill) glass vials
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Manufacturing

Quantoom collaborates with Stevanato to elevate mRNA production

The two companies have entered into a collaboration to promote and democratise access to mRNA production technologies worldwide by launching Quantoom's Nfinity platform
Distribution

DWK enters into distribution agreement with drug containment specialist Stevanato

The collaboration will leverage DWK Life Sciences experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of RTU products
Subscribe now